Andrea L. Ruth Joins AI/ML Innovations Inc. as Head of Quality, Clinical and Regulatory Affairs

AI/ML Innovations Inc. has appointed Andrea L. Ruth as Head of Quality, Clinical, and Regulatory Affairs. With over twenty years in the medical device and biotechnology sectors, Ruth brings extensive expertise in regulatory compliance and quality assurance. Her experience spans global regulatory environments, including the FDA and EMA.

Paul Duffy, CEO of AIML, emphasized Ruth's track record in regulatory compliance as vital to maintaining high standards in AI-driven healthcare solutions. Peter Kendall, President of AIML, highlighted her ability to navigate regulatory changes and enhance operational capabilities.

Ruth expressed enthusiasm about joining AIML, aligning her commitment to innovation with AIML's mission to revolutionize healthcare through cutting-edge AI and machine learning technologies.